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Abstract 
Background: Quality assurance (QA) is a process that should be an integral part of research to protect the rights and 
safety of study participants and to reduce the likelihood that the results are affected by bias in data collection. Most 
QA plans include processes related to study preparation and regulatory compliance, data collection, data analysis and 
publication of study results. However, little detailed information is available on the specific procedures associated with 
QA processes to ensure high‑quality data in multi‑site studies.
Methods: The Global Network for Women’s and Children’s Health Maternal Newborn Health Registy (MNHR) is a 
prospective population‑based registry of pregnancies and deliveries that is carried out in 8 international sites. Since its 
inception, QA procedures have been utilized to ensure the quality of the data. More recently, a training and certifica‑
tion process was developed to ensure that standardized, scientifically accurate clinical definitions are used consist‑
ently across sites. Staff complete a web‑based training module that reviews the MNHR study protocol, study forms 
and clinical definitions developed by MNHR investigators and are certified through a multiple choice examination 
prior to initiating study activities and every six months thereafter. A standardized procedure for supervision and evalu‑
ation of field staff is carried out to ensure that research activites are conducted according to the protocol across all the 
MNHR sites.
Conclusions: We developed standardized QA processes for training, certification and supervision of the MNHR, a 
multisite research registry. It is expected that these activities, together with ongoing QA processes, will help to further 
optimize data quality for this protocol.
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permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
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to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecom‑
mons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
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Plain english summary
All research studies should have quality assurance, as this 
protects the rights and safety of study participants. It also 
improves the quality of data collection and improves the 
likelihood of obtaining true results. Most quality assur-
ance plans cover a variety of topics, including the prep-
aration prior to the study, ethics issues, analysis of data 
and publication of study results. There is limited infor-
mation on the procedures that different studies use to 
ensure data of high quality.
The procedures that we report here were done as part 
of the The Global Network for Women’s and Children’s 
Health Maternal Newborn Health Registy (MNHR), reg-
istry of pregnancies and deliveries that is carried out in 8 
international sites. The MNHR has adoptes quality assur-
ance procedures since its beginning, to ensure the quality 
of the data. More recently we developed a training and 
certification process to ensure that the same clinical defi-
nitions be used across these eight sites. The study staff 
are trained on these defitions with a web-based training 
module which covers the study protocol, study forms and 
clinical definitions. They are later certified before initiat-
ing study activities and every six months thereafter. The 
MNHR also carries out a procedure for supervision and 
evaluation of field staff to ensure that research activites 
are conducted according to the protocol across all sites. 
We expect that all of these activities will help to further 
optimize data quality for this protocol.
Background
Quality assurance (QA) is a process that should be car-
ried out throughout all phases of research to protect the 
rights and safety of study participants, to improve con-
sistency in data and to reduce the likelihood that trial 
results are affected by bias [1, 2]. QA seeks to ensure 
that studies comply with research standards, to detect 
problems early through routine monitoring and to cor-
rect issues through prompt and effective action [3]. Such 
processes should be considered a standard part of all 
research activities.
Most QA plans include processes related to study prep-
aration and regulatory compliance, data collection, data 
analyses and publication of study results [1]. Addition-
ally, multi-site studies generally include common vari-
ables, data collection methodologies and standardized 
protocols. However, although there is consensus on the 
importance of data quality for research, little detailed 
information is available on the specific procedures and 
best practices for QA processes [4]. One research study 
from India recently published a data quality assurance 
protocol, which focused on tools to ensure the accuracy, 
reliability, timeliness, completeness, precision, and integ-
rity of the data [5]. The investigators found that the tools 
helped increase accuracy of data collection throughout 
the research project. With the increasing global emphasis 
on harmonization and data sharing in research, ensur-
ing not only high quality of data but also comparability 
of data across diverse settings is critical to accurate inter-
pretation of findings [6, 7].
The Maternal Newborn Health Registry (MNHR) is a 
prospective, population-based registry of pregnancies 
and deliveries conducted under the auspices of the Global 
Network for Women’s and Children’s Health Research 
(GN), a multi-country research network. The MNHR 
enrolls approximately 60,000 pregnant women each 
year and follows them from early pregnancy through the 
postnatal period [8, 9]. Briefly, its primary purpose is to 
quantify and analyze trends in pregnancy outcomes over 
time across the GN research sites. It also serves as a data 
collection tool for capturing pregnancies, perinatal and 
neonatal outcomes for individual studies [10, 11] and 
provides data to plan future GN studies. Additionally, 
MNHR data are frequently provided to local health offi-
cials who use it to inform and improve clinical care.
Because the MNHR operates in multiple sites in diverse 
low and middle-income countries (LMIC) and collects 
sensitive data on a large scale, QA has been particularly 
integral to ensuring quality data collection since the 
Registry’s inception in 2008. At the start of the MNHR, 
the investigators determined the critical data to collect, 
developed common definitions based on the WHO cri-
teria, and also defined common methods to collect the 
data. In addition, the MNHR introduced a process of 
ongoing data quality monitoring, including metrics to 
assess missingness and accuracy, which was conducted 
both with local research teams and centrally, with a 
process for rapid feedback and resolution of data issues 
(Table 1) [12].
In 2017, in an effort to continously improve the quality 
of data in the MNHR and to further ensure comparabil-
ity across diverse sites, we identified a need to standard-
ize the clinical data collected by field staff across all sites. 
To address this gap, we developed additional procedures 
for training, certification and supervision of all staff 
within the MNHR. In this this paper, we describe the 
development of tools to support the standardization and 
Keywords: Quality assurance, Training for research studies, Adult learning, Quality control, Public health training, 
Global network
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enhanced QA of data collection including a web-based 
standardized training and certification procedure and 
an evaluation tool for consistent supervision of field staff 
at all GN sites. Additionally, we describe our proposed 
approach to evaluate the feasibility and effectiveness of 
these newly-implemented procedures.
Methods
Setting and background
The GN MNHR was established in research sites based in 
Argentina, Guatemala, India (two sites), Kenya, Pakistan 
and Zambia [5]. A site in the the Democratic Republic of 
the Congo (DRC) replaced the site in Argentina in 2013 
and a Bangladeshi site was added in 2019. Investigators 
from each participating site and a partner United States-
based institution, the NICHD and the Data Coordinat-
ing Center (DCC) based at RTI International, comprise 
the GN MNHR subcommittee that oversees all aspects 
of protocol design, study implementation, data analyses 
and publications. The GN MNHR is conducted under 
the auspices of the GN, a multi-disciplinary research net-
work, which is supported by research grants from the 
National Institute of Child Health and Human Develop-
ment (NICHD).
For each site, the Principal Investigator (PI; based at a 
United States university), and the Senior Foreign Inves-
tigator (SFI; based at an international research site) are 
collectively responsible for ensuring the overall quality 
of the site’s data. A country coordinator (CC) provides 
study oversight in the field; one or more study supervi-
sors train and supervise registry administrators (RAs). 
RAs have a variety of backgrounds, and have various 
types and levels of professional training (i.e., midwives, 
community health workers, physicians, nurses, medi-
cal technologists, health assistants, and social workers); 
however, a minimal requirement is community health 
worker level experience. They work with a wide range of 
public and private providers and collect data in multiple 
settings including participants´ homes and health institu-
tions (Fig. 1). The RAs are paid study staff with participa-
tion in ongoing training considered part of their research 
responsibilities.
QA procedures in place since the inception of the MNHR
Study preparation and regulatory compliance
In preparation for implementation of the MNHR, each 
of the GN study sites obtained approval of the study pro-
tocol, consent and case report forms (CRFs) from their 
respective Institutional Review Board both in the US 
and in-country. All research staff were certified in the 
Protection of Human Subjects and Good Clinical Prac-
tices. In accordance with NICHD policy, the study proto-
col, manual of procedures (MOP) and CRFs are publicly 
available through the GN website (https ://gn.rti.org/); de-
identified study data is available for secondary analyses 
through the NICHD Data and Specimen (N-DASH) hub 
(https ://dash.nichd .nih.gov/).
Data collection
Standard operating procedures for data collection are 
detailed in the MNHR MOP which has been in place 
since study inception; it is reviewed annually and updated 
as needed. A question by question (QxQ) document 
defines each study question and is updated as needed; a 
policy document includes technical memos that describe 
new study procedures and outlines the addition or elimi-
nation of variables.
Data processing, analysis and publication
All MNHR data are entered locally into a computer-
based data management system (DMS) that incorpo-
rates inter and intra-form data quality checks. The DCC 
produces monthly monitoring reports which detail site 
and cluster specific metrics to identify issues related to 
Table 1 Elements of the quality assurance plan for the Global Network’s Maternal and Newborn Health Registry
a Recently implemented QA procedures
Study preparation and regulatory compliance Institutional Review Board and Ethical Review Com‑
mittee approved protocol, consents and recruitment 
materials
Curriculum vitaes and documentation of qualifications 
of investigators
Case report forms
Staff  traininga
Data collection Standard operating procedures
Manual of operations
Monitoring plan
Supervisory  visitsa
Data analysis Monthly monitoring reports
Quarterly monitoring metrics
Data Monitoring Committee
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completeness of data collection and to review changes 
in outcomes measure quality improvements over time. 
Specifically, the reports focus on critical data, as defined 
by the central working group to ensure the completeness 
and accuracy of those data elements. Each site reviews 
these monthly monitoring reports and participates in 
quarterly monitoring calls [8]. Study data are reviewed 
annually by a Data Monitoring Committee. A publica-
tion management system outlines specific procedures for 
publication of study results.
QA procedures
In an effort to continuously improve the quality of our 
data collection, we developed a standardized training 
and certification process for RAs as well as standardized 
supervisory procedures.
Training and certification
To improve data collection, including the use of stand-
ardized clinical definitions, we developed a web-based, 
interactive training module for MNHR RAs.
Development and pilot evaluation
Prior to developing the module, we developed stand-
ardized definitions for all clinical data collected in the 
MNHR through an iterative process. First, we reviewed 
the MNHR CRFs and identified all clinical data fields 
(Table 2). We then conducted extensive searches for defi-
nitions of these terms using a variety of sources including 
the WHO and United Nations Population Fund web-
sites as well as technical documents, clinical textbooks 
and peer reviewed journals. Based on these definitions, 
we compiled draft definitions for the MNHR that were 
reviewed by the GN MNHR subcommittee and study site 
investigators, including obstetric and pediatric special-
ists in the GN, for scientific accuracy. The subcommit-
tee further refined these definitions during an in-person 
discussion to ensure they reflected the diagnostic capa-
bility of current healthcare at the MNHR research sites. 
For example, the final MNHR definition for malaria does 
not require confirmatory laboratory testing, as GN sites 
with high malaria prevalence diagnose the disease clini-
cally without routinely performing confirmatory labora-
tory testing. Similarly, the definition of neonatal sepsis 
does not require confirmation with blood culture. Lastly, 
a medical editor reviewed the final draft definitions, 
also ensuring the literacy level was appropriate for the 
level of medical training required of MNHR RAs. As the 
next step, the modules were pilot tested with a sample of 
learners from the sites. These staff provided feedback on 
the definitions as well as the use of pictorial images.
Implementation of web‑based QA
Using these standardized clinical definitions, study pro-
tocol and MOP, the Instituto de Nutrición de Centro 
América y Panamá (INCAP) developed a web-based 
training module with Storyline 360 (https ://360.artic ulate 
.com) software, which supports the development of inter-
active courses for all types of computers and devices. This 
training module was designed using andragogic learn-
ing principles for adults, facilitating knowledge acquisi-
tion by linking new concepts to previous experiences 
and prior knowledge [13]. The course contextualizes the 
learning process to the MNHR setting, so that learners 
can establish an immediate link between theory (such 
as clinical definitions) and its practical application. The 
Principal Invesgator*Senior Foreign Invesgator*
Country coordinator
Supervisor+ Supervisor+
RA+RA+ RA+ RA+ RA+RA
+RA+RA+RA+RA+
* Part of GN MNHR subcommittee
+ Field staff
Fig. 1 Maternal Newborn Health Registry study organization at site
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module covers the study objectives, protocol, and CRFs 
including instructions for use and standardized defini-
tions for all clinical data fields.
This web-based module is available to all sites through 
the GN webpage, which can be accessed through study 
computers or tablets as well as in an off-line mode. The 
module engages learners through key information and 
communication technology. It was developed in English 
and translated into Spanish and French, with subtitles 
appearing throughout the course. If additional languages 
are required, the local staff provide translations. Clini-
cal definitions are communicated with multi-media, 
using text, audio, and an image illustrating the concept. 
Brief quizzes, which require matching the definition to 
the concept after review of every three clinical terms, 
are interspersed throughout the module to help learners 
assess their comprehension. Finally, the course highlights 
achievements of the learner as he/she completes each 
section. Techincal assistance is provided centrally by RTI 
staff, as needed, to complete the modules.
Following the training module, RAs complete a mul-
tiple-choice certification exam (available to all sites 
through the GN webpage or via an electronic copy on 
a storage device). Initial certification, and recertifica-
tion, require a minimum score of 80% on this exam. If 
an RA does not attain this score, he/she receives addi-
tional training from the country coordinator and repeats 
the training module before re-taking the exam. All RAs 
recertify by obtaining a passing grade on the certification 
exam every six months. Additionally, RAs have access to 
the module for additional training whenever necessary. 
Altogether, the training and certification process takes 
approximately 8–10 h for each staff to complete.
Supervisory visits
To improve data collection and study implementation, 
the subcommittee also standardized supervisory proce-
dures of RAs across sites.
First, each site submitted a description of their site-spe-
cific supervisory evaluation process, including any cor-
responding forms. Based on these descriptions and the 
recommendations for implementation of QA processes, 
the subcommittee developed a standardized supervisory 
procedure with corresponding CRF for usage by all sites 
in the MNHR. This CRF assesses general activities of the 
RA, communication with other health providers and a 
field visit, including a key variable check. Country coodi-
nators piloted the supervisory process and forms in each 
site. They informally found the proposed procedures and 
frequency of supervision to be feasible. Additionally, they 
Table 2 Clinical processes of care and health outcomes collected on Maternal and Newborn Health Registry forms, 2019
a Common to more than one period
Pregnancy Delivery Postpartum and neonatal
Outcomes
Ectopic pregnancy
Miscarriage or spontaneous abortion
Induced abortion
Abortive related outcome
Malaria
Syphilis
Hypertensive disease/preeclampsia/eclampsiaa
Fetal or vaginal odor
Other maternal infection
Processes of care
Dilation and curetage or suction
Outcomes
Transverse lie
Oblique lie
Breech lie
Severe antepartum  hemorrhagea
Obstructed/prolonged labor, failure to progress
Obstetric fistula
Severe postpartum  hemorrhagea
Severe infection
Acute inversion of the uterus
Maternal  deatha
Signs of maceration
Stroke/loss of consciousness/paralysis
Stillbirtha
Birth trauma/difficult delivery
Cord complication
Major malformation at birth
Processes of care
Unplanned hospitalization
Antibiotics
Corticosteroids
Oxytocin
Misoprostol
Magnesium Sulphate
Induction of labor
Episiotomy
Blood transfusion
Hysterectomy
Forceps/vacuum extraction delivery
Outcomes
Congenital anomalies
Abdominal wall defect
Neural tube defect
Breathing difficulties
Prematurity
Breathed weekly or did not cry at birth
Fits/seizures of the neonate fever or low 
temperature chest X ray or clinical finding of 
pneumonia
Pus draining from umbilical stump
Asphyxia (neonate)
Sepsis (neonate)
Accident/assault/trauma/suicide
Diabetes
Severe anemia
Severe jaundice
Infection
Seizures
Signs of fetal distress
Processes of care
Required resuscitation at birth
Continued positive airway pressure
Oxygen
Mechanical ventilation
Medicinal eye care
Medicinal cord care
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gave feedback on the data selected for variable checks 
such as using maternal height instead of weight since the 
latter can fluctuate between when an RA records the data 
and a supervisor confirms it. Final variables were selected 
based on their likelihood of being easily recalled by the 
mother and readily obtained during a supervisory home 
visit, and included such items as maternal height, deliv-
ery location, and mode of delivery.
The final, standardized supervisory procedure occurs 
as follows:
Annually, all RAs undergo two supervisory visits con-
sisting of three parts, which are recorded on a study 
form. The supervisor arrives in the community where the 
RA is scheduled and corroborates that he/she is prepared 
with consents, study forms and equipment. The supervi-
sor visits community level or ministry of health staff to 
corroborate that the RA interfaces regularly and appro-
priately with them. Finally, the supervisor visits two ran-
domly selected MNHR participants to corroborate data 
in the DMS for specific key variables. Supervisors review 
the findings of these supervision processes with each RA. 
If necessary, RAs are provided additional training tar-
geting non-compliance with study procedures or errors 
in data collection through the training module or direct 
coaching by supervisors.
Evaluation plan of recently implemented QA procedures
Country coordinators ensure that all RAs complete train-
ing and certification procedures and report on these pro-
cesses to the DCC, which keeps a log of these data. Data 
collected through the supervisory process are entered 
into the DMS and analyzed by the DCC. Results of both 
are discussed on periodic site calls.
To evaluate the impact of these QA methods, the sub-
committee will review the training and certification pro-
cedure for feasibility (such as the number of RAs trained 
and average time for course completion) and effective-
ness (such as certification exam scores and first-time 
pass rate). Through data collected during our supervi-
sory procedure, we will evaluate RA fidelity to the study 
protocol and quality of data collected (such as percent of 
data elements in the DMS that is congruent with partic-
ipant-reported data for each key variable). We will track 
congruency of all key variables on the CRF over time 
to determine whether our QA training is successful at 
improving the quality of the data. Additionally, the cen-
tral QA team reviews the content and updates, as needed, 
on a bi-annual basis.
Discussion
QA is a necessary part of conducting research; best prac-
tices recommend that it includes measures to prevent, 
detect and correct errors from the beginning of data 
collection through the publication of study results. QA 
also helps ensure that data are accurate and collected 
using common methods across sites. This is particularly 
challenging in multi-site, large-scale studies such as the 
MNHR. Multi-site studies need to ensure standardiza-
tion of definitions across diverse settings to help ensure 
generalizability of findings. In addition to the stand-
ardized definitions and procedures, other studies have 
emphasized the importance of leveraging local capacity 
with central technical support, similar to the model of 
the GN [14, 15]. Additionally, as with the GN, the use of 
ongoing data metrics in routine monitoring reports have 
been shown to improve data quality [5, 16].
The MNHR includes participants in eight diverse 
LMIC settings, enrolling approximately sixty thousand 
participants annually. Since its inception ten years ago, 
we designed QA procedures for data collection, entry, 
editing and transmission. In 2012, we added metrics 
and standardized reports to facilitate regular identifica-
tion of site-specific implementation issues. These QA 
procedures have supported the successful enrollment of 
704,265 participants with over 95% followed from preg-
nancy through delivery [9].
Building upon the existing platform of common defini-
tions and ongoing data monitoring, in an effort to con-
tinuously improve the quality of our data in 2017 we 
implemented standardized training and certification as 
well as supervisory procedures with a number of nota-
ble strengths. Our training and certification procedure 
includes newly-developed, standardized definitions for 
all clinical data collected in the MNHR. The web-based 
training module utilizes andragogic learning principles 
and capitalizes on information and communication tech-
nology to engage learners. Recertification of RAs ensures 
that initial proficiency in study procedures is maintained. 
The supervisory procedure facilitates the detection of 
non-compliance with study procedures as well as errors 
in data collection, reporting and entry. All GN sites have 
successfully implemented these training, certification 
and supervisory procedures, and given the relatively low 
additional burden in terms of time and other resources, 
have found that they are feasible to continue. We thus 
view these changes in procedures to be strengths that 
will enhance the utility of this registry for its multiple 
intended purposes.
Despite these strengths, there are limitations to our 
newly-implemented QA procedures. The MNHR data 
are collected via medical record abstraction and inter-
view of participants. While we developed standardized 
clinical definitions to support accurate data collection, 
these definitions do not ensure accurate ascertainment 
and documentation of clinical diagnoses by health care 
providers, nor do they ensure accurate maternal recall. 
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Similarly, while we attempted to verify variables most 
likely to be recalled by the mother during supervisory 
visits, maternal recall is an imperfect ‘gold standard’.
In this manuscript, we have described a comprehen-
sive QA procedure that may serve as a model for other 
multi-site large-scale studies. Through routine MNHR 
review processes, we identified an opportunity to 
improve training and oversight with the goal of assur-
ing strong adherence to a protocol implemented in 
diverse low resource settings. On-going data collection 
regarding these processes will allow us to evaluate their 
feasibility and effectiveness, and to determine critical 
elements for maintaining high quality data for this and 
other similar registry—based protocols.
Conclusion
In conclusion, especially for large, multi-site clini-
cal research studies in LMICs, the ability to harmo-
nize data across diverse settings presents challenges, 
limiting the ability to compare site results. Provid-
ing a standardized training across the sites together 
with reinforced supervision and oversight that is cen-
trally monitored has proven useful in improving qual-
ity of data. The approaches used to facilite QA across 
the MNHR have applicability across other multi-site 
research studies, which have particular challenges in 
ensuring common methodologies and interpretation of 
data.
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